Suppr超能文献

血红素加氧酶-1作为血红素诱导的结直肠癌发生中潜在肿瘤促进因子的病理意义。

Pathological significance of heme oxygenase-1 as a potential tumor promoter in heme-induced colorectal carcinogenesis.

作者信息

Singhabahu Rachitha, Kodagoda Gamage Sujani M, Gopalan Vinod

机构信息

Cancer Molecular Pathology, School of Medicine, Griffith University, Gold Coast, Queensland 4222, Australia.

Faculty of Health Sciences and Medicine, Bond University, Robina 4226, Australia.

出版信息

Cancer Pathog Ther. 2023 Apr 13;2(2):65-73. doi: 10.1016/j.cpt.2023.04.001. eCollection 2024 Apr.

Abstract

The significance of the heme-metabolizing enzyme heme oxygenase-1 (HMOX1) in the pathogenesis of colorectal cancer (CRC) has not been fully explored. HMOX1 cytoprotection is imperative to limit oxidative stress. However, its roles in preventing carcinogenesis in response to high levels of heme are not thoroughly understood. This study reviews various mechanisms associated with the paradoxical role of HMOX1, which is advantageous for tumor growth, refractoriness, and survival of cancer cells amid oxidative stress in heme-induced CRC. The alternate role of HMOX1 promotes cell proliferation and metastasis through immune modulation and angiogenesis. Inhibiting HMOX1 has been found to reverse tumor promotion. Thus, HMOX1 acts as a conditional tumor promoter in CRC pathogenesis.

摘要

血红素代谢酶血红素加氧酶-1(HMOX1)在结直肠癌(CRC)发病机制中的意义尚未得到充分探索。HMOX1的细胞保护作用对于限制氧化应激至关重要。然而,其在应对高水平血红素时预防癌变中的作用尚未被完全理解。本研究综述了与HMOX1矛盾作用相关的各种机制,即在血红素诱导的CRC中,HMOX1在氧化应激下对肿瘤生长、难治性和癌细胞存活具有促进作用。HMOX1的这种交替作用通过免疫调节和血管生成促进细胞增殖和转移。已发现抑制HMOX1可逆转肿瘤促进作用。因此,HMOX1在CRC发病机制中作为一种条件性肿瘤促进因子发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2fb/11002664/07e4a0782556/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验